Viewing StudyNCT00291668



Ignite Creation Date: 2024-05-05 @ 4:42 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00291668
Status: COMPLETED
Last Update Posted: 2020-08-03
First Post: 2006-02-10

Brief Title: Clinical Study of CDP870Certolizumab Pegol in Patients With Active Crohns Disease
Sponsor: UCB Pharma
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Crohns Disease
Keywords:
Name View
Certolizumab pegol View
Crohns Disease View
CDP870 View